Europe Infusion Pump Market

The Europe infusion pump market is projected to reach USD 7.09 billion by 2031 from USD 5.11 billion in 2026, at a CAGR of 6.8% during the forecast period.

The Europe infusion pumps market is fueled by improvements in healthcare infrastructure, an uptick in advanced medical technology adoption, and a focus on patient safety and quality in major countries such as Germany, France, the UK, Italy, and Spain.

To know about the assumptions considered for the study download the pdf brochure

In Europe, the integration of infusion pumps with hospital information technology systems is increasingly common. Integrating EHR systems with infusion pumps enables automatic programming of medication dosing and real-time documentation, which is essential in Europe’s tightly controlled healthcare setting. Additionally, this technology complies with strict regulatory standards, including cybersecurity standards and requirements outlined in European medical device regulations. Moreover, the rising prevalence of chronic diseases such as diabetes, cancer, and cardiovascular diseases, coupled with Europe’s rapidly growing geriatric population, is the main reason demand for infusion therapy is high in Europe.

The rise of home healthcare and outpatient procedures in Europe has driven demand for ambulatory infusion pumps to soar. The healthcare landscape in Europe is gradually moving toward shorter hospital stays while maintaining treatment efficacy, which in turn increases demand for infusion devices that enhance patient compliance and comfort. There is growing demand for innovations in infusion technology that serve diverse patient segments and help identify infusion therapy needs across various European patient populations.

B. Braun SE (Germany); Fresenius Kabi AG (Germany); Baxter International, (US); Becton, Dickinson and Company (BD) (US); Terumo Corporation (Japan); Medtronic (Ireland); NIPRO (Japan) are some of the major players participating in the Europe infusion pump market.

Especially in Germany, players in the European infusion pump market hold a dominant position due to their extensive hospital network spanning all regions of Europe, local production capacity, and compliance with European regulations. Across Europe, the competitive landscape will continue to be shaped by collaborations and acquisitions within strategic partnerships. Collaborations focused on automated insulin delivery and intelligent infusion solutions align well with Europe's emphasis on integrating digital healthcare solutions. Meanwhile, other acquisitions to strengthen infusion solutions in connected care and remote patient monitoring will enable companies to broaden their product range in infusion solutions. Overall, these developments are expected to support further innovation and market penetration throughout the forecasted period in Europe.

B. Braun is a prominent player in the medical technology sector and a leading healthcare supplier, providing products for applications in anesthesia, intensive care, cardiology, extracorporeal blood treatment, and surgery. The Hospital Care segment provides infusion therapy injection systems and clinical nutrition products for inpatient care. B. Braun is present in about 64 countries across North America, Europe, the Asia Pacific, Africa, the Middle East, and Latin America. It has 299 consolidated companies worldwide. Its subsidiaries include B. Braun Surgical GmbH (Germany), B. Braun Medical A/S (Denmark), B. Braun Medical B.V. (Netherlands), B. Braun Medical S.A. (Spain), and B. Braun Aesculap Japan Co. Ltd. (Japan).

Fresenius Kabi AG is a leading entity in the European healthcare sector, dealing with dialysis products, infusion therapy products, and other healthcare-related products & services. The company offers infusion pumps and related accessories through the Medtech segment. Fresenius has an international sales network and maintains over 90 production sites worldwide. The company’s leading production sites are located in the US, China, Japan, Germany, and Sweden. The company’s subsidiaries include Fresenius Medical Care North America (US), Fresenius Kabi Pharmaceuticals Holding (US), Fresenius Kabi USA, Fresenius Kabi Canada, and Fresenius Kabi (Germany).

Market Ranking

The top five companies for the infusion pump market are B. Braun SE (Germany), Fresenius Kabi AG (Germany), Baxter (US), Becton, Dickinson and Company (BD) (US), and Terumo Corporation (Japan).

B.?‍?‌‍?‍‌?‍?‌‍?‍‌ Braun SE (Germany) is at the forefront of the infusion pump market, offering a full range of products that include volumetric, syringe, ambulatory, and smart infusion systems. The company is also highly digitally integrated and has a strong presence in European healthcare systems. Fresenius Kabi AG (Germany) is the second-closest competitor. The company leverages its Agilia infusion platform and connectivity solutions to meet diverse clinical needs while benefiting from strong hospital relationships and a focus on interoperability. Baxter (US) retains its strong position through a continuous commitment to R&D, the introduction of safety features in software-enabled infusion, and a broad global footprint that facilitates the diffusion of the technology in European hospitals. Becton, Dickinson and Company (BD) (US) is enhancing its market position through a broad smart infusion portfolio, the implementation of advanced dose-error reduction features, and strategic moves to accelerate the expansion of its connected care offerings. Terumo Corporation (Japan) is the fifth-ranked company, supported by dependable infusion systems, a strong consumables business, and a growing presence in Europe's hospital care sector.

Related Reports:

Europe Infusion Pump Market by Product [Accessories (Dedicated, Non-Dedicated), Devices (Insulin, Syringe, Volumetric, Enteral, PCA pump)], Application (Chemotherapy, Diabetes, Analgesia), Mode of Administration (Subcutaneous, Epidural) - Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com